V 85546

Drug Profile

V 85546

Alternative Names: AS-111793; MMP-12 inhibitor - Merck Serono; V85546

Latest Information Update: 16 Mar 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Merck Serono; Vernalis
  • Developer Vernalis
  • Class Anti-inflammatories
  • Mechanism of Action Matrix metalloproteinase 12 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Inflammation

Highest Development Phases

  • Suspended Inflammation

Most Recent Events

  • 16 Mar 2016 V 85546 is still available for licensing (http://vernalis.com)
  • 12 Nov 2010 V 85546 is available for licensing for inflammatory disorders in World as of 22 Oct 2008. http://www.vernalis.com/
  • 22 Oct 2008 Vernalis regains all rights to V 85546 from Merck Serono
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top